9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,338 | 11,495 | 5,729 | 8,112 | 10,663 |
| Other current assets | 75 | 175 | 180 | 0 | 0 |
| TOTAL | $14,531 | $12,473 | $6,414 | $8,637 | $10,908 |
| Non-Current Assets | |||||
| PPE Net | 34 | 30 | 35 | 40 | 45 |
| Other Non-Current Assets | 75 | 88 | 6 | 6 | 6 |
| TOTAL | $109 | $118 | $41 | $46 | $51 |
| Total Assets | $14,640 | $12,591 | $6,454 | $8,683 | $10,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,712 | 3,929 | 3,619 | 2,883 | 3,348 |
| Accrued Expenses | 974 | 897 | 826 | 229 | N/A |
| Other current liabilities | 1,659 | 2,293 | 370 | N/A | N/A |
| TOTAL | $9,619 | $10,944 | $10,113 | $8,302 | $7,500 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 29 | 0 | 0 | 0 |
| TOTAL | $15 | $29 | $N/A | $N/A | $N/A |
| Total Liabilities | $9,633 | $10,973 | $10,113 | $8,302 | $7,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,794 | 1,769 | 1,340 | 1,304 | 1,289 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -52,439 | -47,951 | -43,516 | -40,501 | -39,725 |
| TOTAL | $5,006 | $1,618 | $-3,659 | $381 | $3,459 |
| Total Liabilities And Equity | $14,640 | $12,591 | $6,454 | $8,683 | $10,959 |